Ethris Presents Positive Topline Phase 1 Data with mRNA Lead Candidate ETH47 for Uncontrolled Asthma
Dose-dependent target engagement: ETH47 exhibited a clear dose-dependent production of IFNλ in the nasal lining fluid exceeding predicted therapeutic levels. ETH47 administration also activated the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback